Cytodyn Inc (CYDY)

[BreezeWoodAcres]

Here’s my take. The problem I have is that in the trials conducted, we have been given the results which on secondary endpoints NEWS seem statistically significant. Better than any other results because no one has even attempted what was done. Very small trial however which we need phase III. Using NEWS as primary endpoint and for moderate not mild symptoms. In S/C DSMC reviewing at 195. Unless it’s a home run, regardless of just a better outcome the trial will need to be completed to 390. Is it a delay tactic? Quite possibly. But being such a small company, it’s hard to gain any leverage. We are barely mentioned when you hear anything about MABS because of the other two Regeneron and Eli Lilly. So it will be a tough climb. But most of what I want to hear is the reasons behind not being granted EUA. The lingering questions are what is the reason we are being stonewalled. Are the true results really not that impressive? Is Leronlimab not working like it’s supposed to? What will get us to the promised land? All we have to go on is NPs words and timelines which we know where that gets us. 10% lower with each CC and proactive video. The boy who cried wolf too many times while not showing investors any confidence in him. How’s about instead of granting yourself shares, dip into your own cash and make a nice $1 million dollar purchase using own cash. Instill confidence and get the company noticed. Dilution and more waiting will not get it done. GLTA